A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans
- PMID: 15550242
- DOI: 10.1016/j.cell.2004.11.022
A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans
Abstract
The tumor suppressor p53 gene is mutated in minimally half of all cancers. It is therefore reasonable to assume that naturally occurring polymorphic genetic variants in the p53 stress response pathway might determine an individual's susceptibility to cancer. A central node in the p53 pathway is the MDM2 protein, a direct negative regulator of p53. In this report, a single nucleotide polymorphism (SNP309) is found in the MDM2 promoter and is shown to increase the affinity of the transcriptional activator Sp1, resulting in higher levels of MDM2 RNA and protein and the subsequent attenuation of the p53 pathway. In humans, SNP309 is shown to associate with accelerated tumor formation in both hereditary and sporadic cancers. A model is proposed whereby SNP309 serves as a rate-limiting event in carcinogenesis.
Similar articles
-
A high-frequency regulatory polymorphism in the p53 pathway accelerates tumor development.Cancer Cell. 2010 Sep 14;18(3):220-30. doi: 10.1016/j.ccr.2010.07.010. Cancer Cell. 2010. PMID: 20832750 Free PMC article.
-
MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.Clin Cancer Res. 2007 Jul 15;13(14):4123-9. doi: 10.1158/1078-0432.CCR-07-0609. Clin Cancer Res. 2007. PMID: 17634539
-
A single nucleotide polymorphism in the MDM2 gene disrupts the oscillation of p53 and MDM2 levels in cells.Cancer Res. 2007 Mar 15;67(6):2757-65. doi: 10.1158/0008-5472.CAN-06-2656. Cancer Res. 2007. PMID: 17363597
-
Mdmx and Mdm2: brothers in arms?Cell Cycle. 2004 Jul;3(7):900-4. Epub 2004 Jul 2. Cell Cycle. 2004. PMID: 15254433 Review.
-
Polymorphic variants in the p53 pathway.Cell Death Differ. 2006 Jun;13(6):916-20. doi: 10.1038/sj.cdd.4401907. Cell Death Differ. 2006. PMID: 16557270 Review. No abstract available.
Cited by
-
The Role of p53 and MDM2 in Head and Neck Cancer.ISRN Otolaryngol. 2011 Dec 7;2011:931813. doi: 10.5402/2011/931813. Print 2011. ISRN Otolaryngol. 2011. PMID: 23724261 Free PMC article.
-
MDM2 SNP285 does not antagonize the effect of SNP309 in lung cancer.Int J Cancer. 2012 Dec 1;131(11):2710-6. doi: 10.1002/ijc.27573. Epub 2012 Apr 27. Int J Cancer. 2012. PMID: 22487911 Free PMC article.
-
Genetic variation and its role in malignancy.Int J Biomed Sci. 2011 Sep;7(3):158-71. Int J Biomed Sci. 2011. PMID: 23675233 Free PMC article.
-
The CYP19 RS4646 polymorphism IS related to the prognosis of stage I-II and operable stage III breast cancer.PLoS One. 2015 Mar 20;10(3):e0121535. doi: 10.1371/journal.pone.0121535. eCollection 2015. PLoS One. 2015. PMID: 25793413 Free PMC article.
-
SNPs in genes implicated in radiation response are associated with radiotoxicity and evoke roles as predictive and prognostic biomarkers.Radiat Oncol. 2013 May 22;8:125. doi: 10.1186/1748-717X-8-125. Radiat Oncol. 2013. Retraction in: Radiat Oncol. 2018 Apr 26;13(1):79. doi: 10.1186/s13014-018-1027-9 PMID: 23697595 Free PMC article. Retracted.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous